Home › Services › Chimeric Antibody Generation
Before you spend a humanization campaign on a lead, is it worth checking the lead is right?
Usually, yes — and a chimeric antibody is the cheap way to check. We fuse your source variable region to a human IgG constant region, giving you a recombinant molecule that answers three questions quickly: does the clone still work when it is no longer a hybridoma supernatant, does it behave in the isotype your application requires, and does it now play correctly with human-antibody assay reagents. It is a short, standard workflow, and it is the sensible first step before full humanization, which is a longer and more expensive commitment.
What a chimeric antibody gives you
- A function check on a recombinant molecule. Hybridoma supernatant and ascites are not the molecule you will develop. Recombinant expression from a defined VH/VL sequence removes that ambiguity — including the common case of a hybridoma secreting more than one light chain — so what you characterize is what you will carry forward.
- An isotype decision, made empirically. The constant region determines effector function: complement engagement, Fc gamma receptor binding, ADCC and ADCP. Fusing the same variable region to different human constant regions lets you compare isotypes with the paratope held constant, which is the cleanest way to attribute a functional difference to the Fc.
- Reagent compatibility. A mouse or rabbit antibody in an assay that uses human-antibody detection reagents creates species conflicts. A chimeric version with a human constant region is detected by anti-human secondaries and behaves as a human antibody control.
- A benchmark for humanization. The chimeric molecule retains the parent variable region intact, so it is the correct reference against which to judge whether a subsequent humanized construct lost affinity in the graft.
Where it fits in a program
The value of the chimeric step is largely one of sequencing. Humanization is a real engineering campaign — framework selection, Vernier back-mutation, and frequently STEM™ affinity recovery. Running it on a lead that turns out to be the wrong clone, or the wrong isotype, or that does not survive recombinant expression, is expensive in both budget and calendar.
| Situation | Route |
|---|---|
| Need a fast function or isotype check on a non-human lead | Chimeric antibody generation (this service) |
| Lead confirmed, heading toward the clinic from a mouse antibody | Mouse mAb humanization |
| Lead confirmed, heading toward the clinic from a rabbit antibody | Rabbit mAb humanization |
| Single-domain camelid lead | Llama / alpaca VHH humanization |
| Chimeric molecule works but binds too weakly | STEM™ affinity maturation — up to 1,300×, to 4.4 pM |
| Chimeric molecule works but expresses poorly | Expression and titer rescue |
| Veterinary program needing a species-matched constant region | Feline / veterinary antibody engineering |
The same variable-region-to-constant-region fusion also produces species-matched constructs for animal health programs, where the target constant region is that of the species the program targets rather than human rather than human.
You receive
- Chimeric recombinant IgG in the constant region and isotype you specify
- Function-confirmation data against the parent antibody
- Full VH/VL sequences
- No downstream royalties, stage-gated approval before each next step
Frequently asked questions
- What is a chimeric antibody?
- An antibody whose variable regions come from the original source species and whose constant regions come from another species, most often human. The paratope is unchanged, so binding is normally preserved, while the constant region determines effector function and how the molecule is detected by assay reagents.
- What is the difference between a chimeric and a humanized antibody?
- A chimeric antibody replaces only the constant regions, leaving the entire non-human variable domain intact. A humanized antibody goes further, grafting only the CDRs onto human framework regions, which reduces immunogenicity more but requires framework back-mutation and often affinity recovery. Chimeric construction is fast and involves little sequence change; humanization is a full engineering campaign.
- Why make a chimeric antibody before humanizing?
- Because it answers cheaply the questions that would make a humanization campaign wasted: whether the clone still functions as a recombinant molecule rather than as hybridoma supernatant, whether the isotype is right, and whether it behaves correctly with human-antibody assay reagents. It also gives you the correct benchmark for judging affinity loss in the later graft.
- Can you switch isotypes to compare effector function?
- Yes. Fusing the same variable region to different human constant regions holds the paratope constant, so differences in complement engagement, Fc gamma receptor binding, ADCC and ADCP can be attributed to the Fc rather than confounded by paratope differences.
- Can you make chimeras with non-human constant regions?
- Yes. The same workflow produces species-matched constructs for veterinary programs, where the constant region is that of the target species rather than human.
- What do you need from me?
- The VH/VL amino-acid sequence and the constant region and isotype you want. No hybridoma material is required. Contact info@abwizbio.com for a scoped quote.
Abwiz Bio, Inc. — 9823 Pacific Heights Blvd, Suite J, San Diego, CA 92121, USA. Email info@abwizbio.com or use the contact form for a scoped quote.